0 Commentaires
0 Parts
362 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Forums
-
Connectez-vous pour aimer, partager et commenter!
-
Breakthrough Therapies and Innovation Trends Reshaping the Cancer Pain Management Solutions Market by 2031The Cancer Pain Management Solutions Market is undergoing rapid transformation as advancements in therapeutics, digital health technologies, and patient-centric care models redefine oncology support systems.The integration of pharmacological treatments, medical devices, and non-invasive therapies continues to expand the scope of pain management strategies across global healthcare systems....0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Cancer Biologics Market Advances with Growing Innovation in Targeted Therapies and Next-Generation BiopharmaceuticalsAccording to the latest report published by Data Bridge Market Research, the Cancer Biologics Market The global cancer biologics market size was valued at USD 122.55 billion in 2024 and is projected to reach USD 195.62 billion by 2032, with a CAGR of 6.02% during the forecast period of 2025 to 2032. An influential Cancer Biologics Market advertising report puts light on the types...0 Commentaires 0 Parts 795 Vue 0 Aperçu
-
Cancer Therapeutics Market Expands as Pharmaceutical Innovation Transforms Oncology Treatment ApproachesThe Cancer Therapeutics Market was valued at US$ 230.42 Billion in 2024 and is projected to reach US$ 531.53 Billion by 2031, registering a CAGR of 12.68% during 2025–2031. This version emphasizes balanced demand, technology, competition, and execution. Decision-makers should connect market growth to verified customer needs, operating constraints, and measurable value. What is driving the...0 Commentaires 0 Parts 12 Vue 0 Aperçu
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Global Raloxifene Hydrochloride Market Growing at 5.8% CAGR Driven by Dual Benefits in Bone Health & Cancer PreventionAccording to a new report from Intel Market Research, the global Raloxifene Hydrochloride market was valued at USD 1.05 billion in 2025 and is projected to reach USD 1.75 billion by 2034, growing at a steady CAGR of 5.8% during the forecast period (2026-2034). This growth is fueled by increasing osteoporosis prevalence among aging populations, expanding applications in breast cancer prevention,...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
HER2+ Gastric Cancer Market Advances with Targeted Therapy Innovations and Precision Oncology DevelopmentsAccording to the latest report published by Data Bridge Market Research, the HER2+ Gastric Cancer Market The global HER2+ Gastric Cancer market was valued at USD 1.32 billion in 2024 and is expected to reach USD 1.86 billion by 2032During the forecast period of 2025 to 2032 the market is sly to grow at a CAGR of 4.44% This global HER2+ Gastric Cancer Market report is a wonderful...0 Commentaires 0 Parts 913 Vue 0 Aperçu
-
Ipilimumab Market Advances with Expanding Immuno-Oncology Research and Growing Adoption of Targeted Cancer TherapiesAccording to the latest report published by Data Bridge Market Research, the Ipilimumab Market The global Ipilimumab market size was valued at USD 2.14 billion in 2025and is expected to reach USD 4.58 billion by 2033, at a CAGR of 10.00% during the forecast period Global Ipilimumab Market report analyses the key developments taking place with respect to agreements, partnerships,...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Oral Mucositis Drugs Market Advances with Novel Supportive Care Therapies and Growing Oncology Treatment DemandAccording to the latest report published by Data Bridge Market Research, the Oral Mucositis Drugs Market Data Bridge Market Research analyses that the global oral mucositis drugs market which was USD 530.00 million in 2023, would rocket up to USD 896.62 million by 2030, and is expected to undergo a CAGR of 7.80% during the forecast period. This Oral Mucositis Drugs Market research...0 Commentaires 0 Parts 923 Vue 0 Aperçu
-
Streptozocin Market Advances with Ongoing Oncology Research and Expanding Focus on Rare Cancer TherapeuticsAccording to the latest report published by Data Bridge Market Research, the Streptozocin Market The global streptozocin market size was valued at USD 159.40 million in 2025 and is expected to reach USD 232.83 million by 2033, at a CAGR of 4.85% during the forecast period This Streptozocin Market document encompasses several market aspects such as market estimates and forecasts,...0 Commentaires 0 Parts 823 Vue 0 Aperçu
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek